Yvonne Fitz

Critical Care Medicine Department, National Institutes of Health

Affiliated withNational Institutes of Health

Research Area

Medicine

Biography

Yvonne Fitz has not added Biography.
If you are Yvonne Fitz and would like to personalize this page please email our Author Liaison for assistance.

JoVE Journal Publications

ArticleTotal : 1	Year
Publication title Cited by 65	2015

Other Publications

Article	Year
Risk and the efficacy of antiinflammatory agents: retrospective and confirmatory studies of sepsis. American journal of respiratory and critical care medicine\| PubMed ID: 12403688	2002
TGF-beta1 increases microbial clearance but worsens lung injury during Escherichia coli pneumonia in rats. Cytokine\| PubMed ID: 14572790	2003
Lethality during continuous anthrax lethal toxin infusion is associated with circulatory shock but not inflammatory cytokine or nitric oxide release in rats. American journal of physiology. Regulatory, integrative and comparative physiology\| PubMed ID: 14715494	2004
Severity of sepsis alters the effects of superoxide anion inhibition in a rat sepsis model. Journal of applied physiology (Bethesda, Md. : 1985)\| PubMed ID: 15169752	2004
Granulocyte colony-stimulating factor has differing effects comparing intravascular versus extravascular models of sepsis. The Journal of trauma\| PubMed ID: 15454812	2004
Late treatment with a protective antigen-directed monoclonal antibody improves hemodynamic function and survival in a lethal toxin-infused rat model of anthrax sepsis. The Journal of infectious diseases\| PubMed ID: 15633102	2005
Neutrophil inhibition with L-selectin-directed MAb improves or worsens survival dependent on the route but not severity of infection in a rat sepsis model. Journal of applied physiology (Bethesda, Md. : 1985)\| PubMed ID: 15677732	2005
Effective dosing of lipid A analogue E5564 in rats depends on the timing of treatment and the route of Escherichia coli infection. The Journal of infectious diseases\| PubMed ID: 16453258	2006
Sublethal doses of Bacillus anthracis lethal toxin inhibit inflammation with lipopolysaccharide and Escherichia coli challenge but have opposite effects on survival. The Journal of infectious diseases\| PubMed ID: 16479518	2006
Parthenolide has limited effects on nuclear factor-kappa beta increases and worsens survival in lipopolysaccharide-challenged C57BL/6J mice. Cytokine\| PubMed ID: 16720096	2006
DTPA Fe(III) decreases cytokines and hypotension but worsens survival with Escherichia coli sepsis in rats. Intensive care medicine\| PubMed ID: 16775718	2006
Bacillus anthracis edema and lethal toxin have different hemodynamic effects but function together to worsen shock and outcome in a rat model. The Journal of infectious diseases\| PubMed ID: 17230417	2007
Fluid support worsens outcome and negates the benefit of protective antigen-directed monoclonal antibody in a lethal toxin-infused rat Bacillus anthracis shock model. Critical care medicine\| PubMed ID: 17452924	2007
Risk of death does not alter the efficacy of hydrocortisone therapy in a mouse E. coli pneumonia model: risk and corticosteroids in sepsis. Intensive care medicine\| PubMed ID: 17992512	2008
Ethyl pyruvate decreased early nuclear factor-kappaB levels but worsened survival in lipopolysaccharide-challenged mice. Critical care medicine\| PubMed ID: 18176313	2008
Norepinephrine increases blood pressure but not survival with anthrax lethal toxin in rats. Critical care medicine\| PubMed ID: 19242337	2009
Bacillus anthracis cell wall produces injurious inflammation but paradoxically decreases the lethality of anthrax lethal toxin in a rat model. Intensive care medicine\| PubMed ID: 19756496	2010
SB203580, a p38 inhibitor, improved cardiac function but worsened lung injury and survival during Escherichia coli pneumonia in mice. The Journal of trauma\| PubMed ID: 20068480	2010
Anthrax edema toxin has cAMP-mediated stimulatory effects and high-dose lethal toxin has depressant effects in an isolated perfused rat heart model. American journal of physiology. Heart and circulatory physiology\| PubMed ID: 21217068	2011
The effect of heparin administration in animal models of sepsis: a prospective study in Escherichia coli-challenged mice and a systematic review and metaregression analysis of published stud... Critical care medicine\| PubMed ID: 21317646	2011
Delayed treatment with W1-mAb, a chimpanzee-derived monoclonal antibody against protective antigen, reduces mortality from challenges with anthrax edema or lethal toxin in rats and with anth... Critical care medicine\| PubMed ID: 21336113	2011
The individual survival benefits of tumor necrosis factor soluble receptor and fluid administration are not additive in a rat sepsis model. Intensive care medicine\| PubMed ID: 21922303	2011
B. anthracis edema toxin increases cAMP levels and inhibits phenylephrine-stimulated contraction in a rat aortic ring model. American journal of physiology. Heart and circulatory physiology\| PubMed ID: 23585140	2013
Bacillus anthracis cell wall peptidoglycan but not lethal or edema toxins produces changes consistent with disseminated intravascular coagulation in a rat model. The Journal of infectious diseases\| PubMed ID: 23737601	2013
Purified cell wall from the probiotic bacterium Lactobacillus gasseri activates systemic inflammation and, at higher doses, produces lethality in a rat model. Critical care (London, England)\| PubMed ID: 24989885	2014